Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acids for Prevention of Psychosis in Adolescents
NCT00396643Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2004
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in psychotic disorders, sponsored by Medical University of Vienna. Started May 2004; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
psychotic disorders
Beyond the preview
Go deeper on NCT00396643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396643.